Medicare Enrolled
Dr. Fariborz Nazari-Adli, M.D.
Family Medicine · Baytown, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nazari-Adli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nazari-Adli? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nazari-Adli
Dr. Fariborz Nazari-Adli is a family medicine in Baytown, TX, with 19 years in practice. Based on federal Medicare data, Dr. Nazari-Adli performed 1,255 Medicare services across 363 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nazari-Adli received a total of $24,444 from 84 pharmaceutical and/or device companies across 1686 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nazari-Adli is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 23% volume in TX$ $24,444 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,255
Medicare services
Top 23% in TX for family medicine
363
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~66 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 391 | $67 | $98 |
| Remote patient monitoring management, 20 min/month | 158 | $39 | $160 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 88 | $32 | $130 |
| Drug injection, under skin or into muscle | 87 | $10 | $25 |
| Ceftriaxone antibiotic injection | 85 | $0 | $20 |
| Remote patient monitoring device, 30 days | 74 | $39 | $200 |
| Urinalysis, manual | 54 | $3 | $15 |
| Blood draw (venipuncture) | 53 | $8 | $19 |
| Complete ultrasound study of arm and leg arteries | 50 | $103 | $280 |
| Office visit, established patient (30-39 min) | 47 | $89 | $131 |
| Injection, methylprednisolone acetate, 80 mg | 39 | $8 | $60 |
| Blood glucose (sugar) test performed by hand-held instrument | 36 | $3 | $19 |
| Testing of autonomic nervous system function and heart rate response to deep breathing | 25 | $45 | $410 |
| Testing of autonomic (sympathetic) nervous system function | 25 | $68 | $410 |
| Influenza vaccine, quadrivalent derived from cell cultures | 15 | $32 | $40 |
| Flu vaccine administration | 15 | $24 | $25 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $17 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,444
Total received (2018-2024)
Avg $3,492/year across 7 years
Top 1% in TX for family medicine
84
Companies
1,686
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,149 (94.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,295 (5.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,702
2023$3,837
2022$3,245
2021$4,568
2020$3,208
2019$3,144
2018$2,740
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,123
Novo Nordisk Inc
$1,358
Lilly USA, LLC
$1,326
Biohaven Pharmaceuticals, Inc.
$1,295
PFIZER INC.
$1,219
Dexcom, Inc.
$941
GlaxoSmithKline, LLC.
$854
ABBVIE INC.
$837
Boehringer Ingelheim Pharmaceuticals, Inc.
$798
Amgen Inc.
$793
Mannkind Corporation
$792
Paratek Pharmaceuticals, Inc.
$733
Otsuka America Pharmaceutical, Inc.
$605
Bayer Healthcare Pharmaceuticals Inc.
$569
Merck Sharp & Dohme Corporation
$546
Sunovion Pharmaceuticals Inc.
$538
MannKind Corporation
$491
Medtronic, Inc.
$467
Bayer HealthCare Pharmaceuticals Inc.
$444
Kowa Pharmaceuticals America, Inc.
$431
AbbVie Inc.
$373
Allergan, Inc.
$341
Horizon Therapeutics plc
$332
Takeda Pharmaceuticals U.S.A., Inc.
$326
Teva Pharmaceuticals USA, Inc.
$324
Supernus Pharmaceuticals, Inc.
$319
Esperion Therapeutics, Inc.
$318
Insulet Corporation
$293
Janssen Pharmaceuticals, Inc
$286
Antares Pharma, Inc.
$262
Endo Pharmaceuticals Inc.
$243
Astellas Pharma US Inc
$235
SANOFI-AVENTIS U.S. LLC
$230
Amarin Pharma Inc.
$228
Allergan Inc.
$217
Merck Sharp & Dohme LLC
$211
Abbott Laboratories
$190
Currax Pharmaceuticals LLC
$180
DEXCOM, INC.
$151
Medtronic MiniMed, Inc.
$121
EISAI INC.
$120
Exact Sciences Corporation
$106
Cumberland Pharmaceuticals, Inc.
$96
Lundbeck LLC
$96
IDORSIA PHARMACEUTICALS US INC
$91
Tandem Diabetes Care, Inc.
$91
Novartis Pharmaceuticals Corporation
$89
Indivior Inc.
$86
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$82
Eisai Inc.
$77
Mylan Specialty L.P.
$75
Ironwood Pharmaceuticals, Inc
$72
Actelion Pharmaceuticals US, Inc.
$64
JAZZ PHARMACEUTICALS INC.
$59
Philips Electronics North America Corporation
$57
RedHill Biopharma Inc.
$51
Global Blood Therapeutics, Inc.
$50
Tolmar, Inc.
$49
Scilex Pharmaceuticals Inc.
$45
IRONWOOD PHARMACEUTICALS, INC
$45
Phathom Pharmaceuticals, Inc.
$43
Melinta Therapeutics, Inc.
$42
Boston Scientific Corporation
$39
Nabriva Therapeutics, plc
$38
Masimo Corporation
$38
Celgene Corporation
$37
ERMI Inc.
$34
Biohaven Pharmaceutical Holding Company Ltd.
$34
Arbor Pharmaceuticals, Inc.
$31
Horizon Pharma plc
$26
Ferring Pharmaceuticals Inc.
$26
CeQur Corporation
$21
Orexo US, Inc.
$20
Assertio Therapeutics, Inc.
$19
Inspire Medical Systems, Inc.
$19
Vertical Pharmaceuticals, LLC
$18
Acerus Pharmaceuticals Corporation
$17
Exeltis, USA Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$17
Gilead Sciences, Inc.
$15
Iroko Pharmaceuticals, LLC
$14
Clarus Therapeutics Inc.
$14
Azurity Pharmaceuticals, Inc.
$14
VIVUS LLC
$11
Top 3 companies account for 19.7% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ABILIFY MAINTENA · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APTIOM · Aimovig · Amitiza · BAQSIMI · BELSOMRA · BREO · BREZTRI · BROVANA · BYDUREON · BYSTOLIC · Baxdela · Belviq · BodyGuardian · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CeQur Simplicity · Cologuard Collection Kit · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIFICID · DUEXIS · Dexcom CGM · Dexcom G6 Transmitter · EDEX · ELIQUIS · EMGALITY · EUCRISA · EUFLEXXA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLECTOR · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GATTEX · Guardian Connect · HUMALOG · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · JANUVIA · JARDIANCE · JATENZO · KRYSTEXXA · Kerendia · Kristalose 20gm · LEQVIO · LINZESS · LIVALO · LONHALA MAGNAIR · LORZONE · LYRICA · LYUMJEV · Linzess · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYRBETRIQ · Minimed 630G · Minimed 670G System · Motegrity · Myrbetriq · NASCOBAL · NEXLETOL · NOCDURNA · NURTEC ODT · NUZYRA · Natesto · OFEV · ONZETRA XSAIL · OPSUMIT · OXBRYTA · Omeclamox · Omnipod · Otezla · Ozempic · PENNSAID · PRALUENT · PREVNAR 20 · Patient SafetyNet System · Perforomist · ProAir Digihaler · Prolia · QULIPTA · QUVIVIQ · Qsymia · RAYOS · REXULTI · RYBELSUS · Repatha · Rybelsus · SEEBRI · SEGLENTIS · SHINGRIX · SIVEXTRO · SLYND · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STIOLTO RESPIMAT · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · SYMBICORT · Saxenda · Seglentis · TIVORBEX · TOUJEO · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · Talicia · Tresiba · Trintellix · UBRELVY · UTIBRON · UTIBRON NEOHALER · Uloric · Utibron · VERQUVO · VOQUEZNA · VRAYLAR · VYEPTI · Vascepa · Veozah · Victoza · XARELTO · XIAFLEX · XIFAXAN · XYOSTED · Xenleta · Xultophy 100/3.6 · Yupelri · ZERBAXA · ZORYVE · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · Zubsolv · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in TX.
Equivalent to $1,948 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
621
Per 100K population
13.1
County median income
$73,104
Nearest hospital
HOUSTON METHODIST BAYTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nazari-Adli is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX), and high industry engagement (low-engagement, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nazari-Adli experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Nazari-Adli performed 391 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nazari-Adli receive payments from pharmaceutical companies?
Yes. Dr. Nazari-Adli received a total of $24,444 from 84 companies across 1,686 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nazari-Adli's costs compare to other family medicines in Baytown?
Dr. Nazari-Adli's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nazari-Adli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Baytown
Browse family medicines in Baytown ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology